OTCMKTS:CMLFU

CM Life Sciences Competitors

$16.58

-0.87 (-4.99 %)

(As of 04/9/2021 12:00 AM ET)

Add

Compare

Today's Range

$16.49

Now: $16.58▼

$17.25

50-Day Range

$15.36

MA: $19.39▼

$27.42

52-Week Range

$10.00

Now: $16.58▼

$30.80

Volume42,682 shs

Average Volume147,166 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

CM Life Sciences (OTCMKTS:CMLFU) Vs. SCCB, ACEVU, ACKIU, ADRAU, ADEXU, and IMPXU

Should you be buying CMLFU stock or one of its competitors? Companies in the industry of "--" are considered alternatives and competitors to CM Life Sciences, including 378 (SCCB), ACE Convergence Acquisition (ACEVU), Ackrell SPAC Partners I (ACKIU), Adara Acquisition (ADRAU), Adit EdTech Acquisition (ADEXU), and AEA-Bridges Impact (IMPXU).

CM Life Sciences vs. 378 Stock

378 (OTCMKTS:SCCB) and CM Life Sciences (OTCMKTS:CMLFU) are both -- companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability.

Profitability

This table compares 378 and CM Life Sciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
378	N/A	N/A	N/A
CM Life Sciences	N/A	N/A	N/A

Valuation & Earnings

This table compares 378 and CM Life Sciences' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
378	N/A	N/A	N/A	N/A	N/A
CM Life Sciences	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and target prices for 378 and CM Life Sciences, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
378	0	0	0	0	N/A
CM Life Sciences	0	0	0	0	N/A

CM Life Sciences vs. ACE Convergence Acquisition Stock

ACE Convergence Acquisition (OTCMKTS:ACEVU) and CM Life Sciences (OTCMKTS:CMLFU) are both -- companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership.

Analyst Ratings

This is a summary of recent recommendations and price targets for ACE Convergence Acquisition and CM Life Sciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ACE Convergence Acquisition	0	0	0	0	N/A
CM Life Sciences	0	0	0	0	N/A

Profitability

This table compares ACE Convergence Acquisition and CM Life Sciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ACE Convergence Acquisition	N/A	N/A	N/A
CM Life Sciences	N/A	N/A	N/A

Valuation & Earnings

This table compares ACE Convergence Acquisition and CM Life Sciences' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ACE Convergence Acquisition	N/A	N/A	N/A	N/A	N/A
CM Life Sciences	N/A	N/A	N/A	N/A	N/A

CM Life Sciences vs. Ackrell SPAC Partners I Stock

CM Life Sciences (OTCMKTS:CMLFU) and Ackrell SPAC Partners I (OTCMKTS:ACKIU) are both -- companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends.

Analyst Recommendations

This is a breakdown of recent ratings for CM Life Sciences and Ackrell SPAC Partners I, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CM Life Sciences	0	0	0	0	N/A
Ackrell SPAC Partners I	0	0	0	0	N/A

Profitability

This table compares CM Life Sciences and Ackrell SPAC Partners I's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CM Life Sciences	N/A	N/A	N/A
Ackrell SPAC Partners I	N/A	N/A	N/A

Earnings and Valuation

This table compares CM Life Sciences and Ackrell SPAC Partners I's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CM Life Sciences	N/A	N/A	N/A	N/A	N/A
Ackrell SPAC Partners I	N/A	N/A	N/A	N/A	N/A

CM Life Sciences vs. Adara Acquisition Stock

Adara Acquisition (OTCMKTS:ADRAU) and CM Life Sciences (OTCMKTS:CMLFU) are both -- companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Valuation & Earnings

This table compares Adara Acquisition and CM Life Sciences' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adara Acquisition	N/A	N/A	N/A	N/A	N/A
CM Life Sciences	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Adara Acquisition and CM Life Sciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Adara Acquisition	N/A	N/A	N/A
CM Life Sciences	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current recommendations for Adara Acquisition and CM Life Sciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adara Acquisition	0	0	0	0	N/A
CM Life Sciences	0	0	0	0	N/A

CM Life Sciences vs. Adit EdTech Acquisition Stock

Adit EdTech Acquisition (OTCMKTS:ADEXU) and CM Life Sciences (OTCMKTS:CMLFU) are both -- companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

Profitability

This table compares Adit EdTech Acquisition and CM Life Sciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Adit EdTech Acquisition	N/A	N/A	N/A
CM Life Sciences	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Adit EdTech Acquisition and CM Life Sciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adit EdTech Acquisition	0	0	0	0	N/A
CM Life Sciences	0	0	0	0	N/A

Valuation & Earnings

This table compares Adit EdTech Acquisition and CM Life Sciences' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adit EdTech Acquisition	N/A	N/A	N/A	N/A	N/A
CM Life Sciences	N/A	N/A	N/A	N/A	N/A

CM Life Sciences vs. AEA-Bridges Impact Stock

AEA-Bridges Impact (OTCMKTS:IMPXU) and CM Life Sciences (OTCMKTS:CMLFU) are both -- companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

Profitability

This table compares AEA-Bridges Impact and CM Life Sciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AEA-Bridges Impact	N/A	N/A	N/A
CM Life Sciences	N/A	N/A	N/A

Earnings and Valuation

This table compares AEA-Bridges Impact and CM Life Sciences' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AEA-Bridges Impact	N/A	N/A	N/A	N/A	N/A
CM Life Sciences	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and price targets for AEA-Bridges Impact and CM Life Sciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AEA-Bridges Impact	0	0	0	0	N/A
CM Life Sciences	0	0	0	0	N/A